Human Growth Hormone Market 2023-2030 is Set To Fly High | Major Players are Novo Nordisk, Merck KGaA, Eli Lilly & Company
Human Growth Hormone Market Overview
Human growth hormone (HGH) Market has gained significant attention in recent years due
to its potential benefits for overall health and well-being. As more people
seek ways to enhance their physical performance, improve muscle growth, and
slow down the aging process, the demand for human growth hormone continues to
rise. The human growth hormone market has witnessed substantial growth in
recent years. According to market research, the market size was valued at USD 4,946.64
Million in 2022 and is expected to grow at a CAGR of 8.2% during the forecast
period.
Market
Definition:
Human growth
hormone (HGH) is a naturally occurring hormone produced by the pituitary gland.
It plays a crucial role in stimulating growth, cell regeneration, and
maintaining healthy body composition. Over the years, the demand for synthetic
HGH has increased due to its potential benefits in various fields.
Factors Driving the Market Growth
Growing
awareness about the benefits of human growth hormone (HGH) is a significant
driver for market growth. As more information becomes available about the
potential advantages of HGH in promoting growth, muscle development, and
overall well-being, there is an increased demand for HGH products.
The demand
for HGH is fuelled by athletes and bodybuilders seeking performance enhancement.
HGH is believed to improve muscle strength, endurance, and recovery time,
making it attractive for individuals involved in sports and athletics. The
global aging population is a major driver for the human growth hormone market.
As individuals age, the natural production of growth hormone declines, leading
to various age-related issues. The desire to maintain vitality, slow down the
aging process, and address age-related symptoms contributes to the growing
demand for HGH.
Click Here: To Get Human
Growth Hormone Market Full Report
Market Challenges
The human
growth hormone market is subject to strict regulatory restrictions in many
countries. HGH is classified as a prescription drug, and its use is tightly
regulated. Obtaining a prescription and ensuring compliance with regulatory
requirements can pose challenges for individuals seeking HGH therapy.
Human growth
hormone therapy can be expensive, making it less accessible to a significant
portion of the population. The high cost of HGH products, combined with the
need for long-term therapy, can present financial challenges for individuals
and healthcare systems. While HGH therapy can offer potential benefits, it is
not without risks. Safety concerns, including short-term and long-term side
effects, pose challenges for both healthcare providers and individuals
considering HGH treatment. Close monitoring and careful evaluation of the risks
and benefits are necessary to ensure safe usage.
Key Players in the Human Growth Hormone Market
Several
companies are actively involved in the production and distribution of human
growth hormone. The key players in the market include:
·
Novo
Nordisk
·
Merck
KGaA
·
Eli
Lilly & Company
·
Pfizer
Inc.
·
Teva
Pharmaceutical Industries Ltd.
·
Novartis,
AnkeBio Co., Ltd
·
Roche
·
Ipsen
Biopharmaceuticals, Inc.
·
Genentech,
Inc.
Market Segmentation:
The human
growth hormone market can be segmented based on various factors, including:
By Route of Administration
·
Subcutaneous
·
Oral
·
Intramuscular
·
Intravenous
·
Others
By Application
·
Growth
Hormone Deficiency
·
Prader-Willi
Syndrome
·
Idiopathic
Short Stature
·
Turner
Syndrome
·
Others
By
Distribution Channel
·
Hospitals
·
Retail
Pharmacies
·
Online
Pharmacies
·
Others
Regional Analysis:
North
America is a significant market for human growth hormone. The region has
well-established healthcare infrastructure, advanced research facilities, and a
high prevalence of growth hormone deficiency. The United States holds the
largest share in the North American market, driven by increasing awareness,
rising demand for performance enhancement, and a growing aging population.
Europe is
another prominent market for human growth hormone growth. Countries such as Germany, the United Kingdom, France, and
Italy are the key contributors to the market in this region. Factors driving
market growth in Europe include a high prevalence of growth hormone deficiency,
robust healthcare systems, and increasing awareness about the benefits of HGH
therapy.
The
Asia-Pacific region is experiencing significant growth in the human growth
hormone market. Rapid economic development, increasing healthcare expenditure,
and a large population base contribute to the expanding market. Countries such
as China, Japan, India, and South Korea are major players in this region.
Recent
Developments:
Novo Nordisk Receives FDA Approval
for Norditropin® FlexPro® Pen (2021): In 2021, Novo Nordisk, a leading pharmaceutical company,
received approval from the U.S. Food and Drug Administration (FDA) for its
Norditropin® FlexPro® Pen. This device is designed for the administration of
human growth hormone therapy, providing patients with a convenient and
user-friendly option for treatment.
Pfizer Launches Genotropin MiniQuick®
Pen (2020): Pfizer,
a global pharmaceutical company, introduced the Genotropin MiniQuick® Pen in
2020. This innovative device allows for the easy and precise administration of
human growth hormone therapy. The pen is designed for on-the-go use and offers
flexibility for patients requiring growth hormone treatment.
About CBI
Consegic Business Intelligence Pvt
Ltd. is the leading research industry that offers
contextual and data-centric research services to its customers across the
globe. The firm assists its clients to strategize business policies and
accomplish sustainable growth in their respective market domains. The industry
provides consulting services, syndicated research reports, and customized
research reports.
Topnotch research organizations and institutions to
comprehend the regional and global commercial status use the data produced by
Consegic Business Intelligence Pvt Ltd. Our reports comprise in-depth
analytical and statistical analysis on various industries in foremost countries
around the globe.
Contact us:
Consegic Business intelligence Pvt
Ltd.
Comments
Post a Comment